Skip to main content
eScholarship
Open Access Publications from the University of California

UCSF

UC San Francisco Previously Published Works bannerUCSF

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: results from the DAYBREAK open-label extension study

Creative Commons 'BY-NC' version 4.0 license
Main Content
For improved accessibility of PDF content, download the file to your device.
Current View